Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Cyproterone Acetate
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
GREEN
Co-Cyprindiol 2000/35
(Cyproterone Acetate 2mg with Ethinylestradiol 35micrograms)
Skin, Hormone treatment for acne, 13.06.02
SCG
Cyproterone Acetate
(For gender dysphoria)
Endocrine system, Anti-androgens, 06.04.02
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local
BNF
Section
Cyproterone
Cyproterone Acetate
Endocrine System, Anti-Androgens
Sex Hormone Responsive Conditions, Male Sex Hormone Responsive Conditions, Male Sex Hormone Antagonism
Cyproterone
Cyproterone Acetate
Malignant Disease, Anti-Androgens
Hormone Responsive Malignancy
Links found
MHRA Drug Safety Update (June 2013) - Cyproterone acetate with ethinylestradiol (co-cyprindiol): balance of benefits and risks remains positive
MHRA Drug Safety Update (June 2013) - Cyproterone acetate with ethinylestradiol (co-cyprindiol): balance of benefits and risks remains positive
MHRA Drug Safety Update: Cyproterone acetate: new advice to minimise risk of meningioma (June 2020)